Putting the Cardiovascular Safety of Aromatase Inhibitors in Patients with Early Breast Cancer into Perspective: A Systematic Review of the Literature

Author： Younus Muhammad  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.12, 2011-12, pp. : 1125-1149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Safety Profiles of Aromatase Inhibitors: A Comparative Review

By Nabholtz Jean-Marc  

Drug Safety, Vol. 29, Iss. 9, 2006-01 ,pp. : 785-801

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors for female infertility: a systematic review of the literature

By Polyzos Nikolaos P.   Tzioras Spyridon   Badawy Ahmed M.   Valachis Antonis   Dritsas Charalabos   Mauri Davide  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 456-471

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Aromatase Inhibitors in Postmenopausal Breast Cancer Patients

By Rieber Alyssa G.   Theriault Richard L.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 3, 2005-05 ,pp. : 309-314

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Safety issues surrounding the use of aromatase inhibitors in breast cancer

By Jackson J   Miller WR   Dixon JM  

Expert Opinion on Drug Safety, Vol. 2, Iss. 1, 2003-01 ,pp. : 73-86

Informa Healthcare

Access to resources Recommend Favorite

Aromatase Inhibitors in Breast Cancer: A Review of Cost Considerations and Cost Effectiveness

By Karnon Jonathan  

PharmacoEconomics, Vol. 24, Iss. 3, 2006-01 ,pp. : 215-232

Adis International

Access to resources Recommend Favorite